Global Vaccine Adjuvants Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 112

Published Date: 18 Mar 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

According to our (Global Info Research) latest study, the global Vaccine Adjuvants market size was valued at USD 877.5 million in 2022 and is forecast to a readjusted size of USD 1564.6 million by 2029 with a CAGR of 8.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The top 5 global manufacturers of vaccine adjuvants are GSK, CSL Limited, Croda, SEPPIC, Novavax, which have a combined market share of about 55 percent. North America is the largest market, with a share about 38%, followed by Europe and Asia Pacific with the share about 27% and 22%.

This report is a detailed and comprehensive analysis for global Vaccine Adjuvants market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Vaccine Adjuvants market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Vaccine Adjuvants market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Vaccine Adjuvants market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Vaccine Adjuvants market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Vaccine Adjuvants
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Vaccine Adjuvants market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, CSL Limited, Croda, SEPPIC and Novavax, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Vaccine Adjuvants market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Aluminum Adjuvant
    Emulsions Adjuvant
    Others

Market segment by Application
    Human Vaccine
    Veterinary Vaccine

Major players covered
    GSK
    CSL Limited
    Croda
    SEPPIC
    Novavax
    SPI Pharma
    Phibro
    SDA BIO
    Invivogen
    Tj Kaiwei
    OZ Biosciences
    Brenntag Biosector
    MVP Laboratories
    Zhuoyue
    Aphios

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaccine Adjuvants product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vaccine Adjuvants, with price, sales, revenue and global market share of Vaccine Adjuvants from 2018 to 2023.
Chapter 3, the Vaccine Adjuvants competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccine Adjuvants breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Vaccine Adjuvants market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vaccine Adjuvants.
Chapter 14 and 15, to describe Vaccine Adjuvants sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Vaccine Adjuvants
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Vaccine Adjuvants Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Aluminum Adjuvant
        1.3.3 Emulsions Adjuvant
        1.3.4 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Vaccine Adjuvants Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Human Vaccine
        1.4.3 Veterinary Vaccine
    1.5 Global Vaccine Adjuvants Market Size & Forecast
        1.5.1 Global Vaccine Adjuvants Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Vaccine Adjuvants Sales Quantity (2018-2029)
        1.5.3 Global Vaccine Adjuvants Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 GSK
        2.1.1 GSK Details
        2.1.2 GSK Major Business
        2.1.3 GSK Vaccine Adjuvants Product and Services
        2.1.4 GSK Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 GSK Recent Developments/Updates
    2.2 CSL Limited
        2.2.1 CSL Limited Details
        2.2.2 CSL Limited Major Business
        2.2.3 CSL Limited Vaccine Adjuvants Product and Services
        2.2.4 CSL Limited Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 CSL Limited Recent Developments/Updates
    2.3 Croda
        2.3.1 Croda Details
        2.3.2 Croda Major Business
        2.3.3 Croda Vaccine Adjuvants Product and Services
        2.3.4 Croda Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Croda Recent Developments/Updates
    2.4 SEPPIC
        2.4.1 SEPPIC Details
        2.4.2 SEPPIC Major Business
        2.4.3 SEPPIC Vaccine Adjuvants Product and Services
        2.4.4 SEPPIC Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 SEPPIC Recent Developments/Updates
    2.5 Novavax
        2.5.1 Novavax Details
        2.5.2 Novavax Major Business
        2.5.3 Novavax Vaccine Adjuvants Product and Services
        2.5.4 Novavax Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Novavax Recent Developments/Updates
    2.6 SPI Pharma
        2.6.1 SPI Pharma Details
        2.6.2 SPI Pharma Major Business
        2.6.3 SPI Pharma Vaccine Adjuvants Product and Services
        2.6.4 SPI Pharma Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 SPI Pharma Recent Developments/Updates
    2.7 Phibro
        2.7.1 Phibro Details
        2.7.2 Phibro Major Business
        2.7.3 Phibro Vaccine Adjuvants Product and Services
        2.7.4 Phibro Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Phibro Recent Developments/Updates
    2.8 SDA BIO
        2.8.1 SDA BIO Details
        2.8.2 SDA BIO Major Business
        2.8.3 SDA BIO Vaccine Adjuvants Product and Services
        2.8.4 SDA BIO Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 SDA BIO Recent Developments/Updates
    2.9 Invivogen
        2.9.1 Invivogen Details
        2.9.2 Invivogen Major Business
        2.9.3 Invivogen Vaccine Adjuvants Product and Services
        2.9.4 Invivogen Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Invivogen Recent Developments/Updates
    2.10 Tj Kaiwei
        2.10.1 Tj Kaiwei Details
        2.10.2 Tj Kaiwei Major Business
        2.10.3 Tj Kaiwei Vaccine Adjuvants Product and Services
        2.10.4 Tj Kaiwei Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Tj Kaiwei Recent Developments/Updates
    2.11 OZ Biosciences
        2.11.1 OZ Biosciences Details
        2.11.2 OZ Biosciences Major Business
        2.11.3 OZ Biosciences Vaccine Adjuvants Product and Services
        2.11.4 OZ Biosciences Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 OZ Biosciences Recent Developments/Updates
    2.12 Brenntag Biosector
        2.12.1 Brenntag Biosector Details
        2.12.2 Brenntag Biosector Major Business
        2.12.3 Brenntag Biosector Vaccine Adjuvants Product and Services
        2.12.4 Brenntag Biosector Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Brenntag Biosector Recent Developments/Updates
    2.13 MVP Laboratories
        2.13.1 MVP Laboratories Details
        2.13.2 MVP Laboratories Major Business
        2.13.3 MVP Laboratories Vaccine Adjuvants Product and Services
        2.13.4 MVP Laboratories Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 MVP Laboratories Recent Developments/Updates
    2.14 Zhuoyue
        2.14.1 Zhuoyue Details
        2.14.2 Zhuoyue Major Business
        2.14.3 Zhuoyue Vaccine Adjuvants Product and Services
        2.14.4 Zhuoyue Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Zhuoyue Recent Developments/Updates
    2.15 Aphios
        2.15.1 Aphios Details
        2.15.2 Aphios Major Business
        2.15.3 Aphios Vaccine Adjuvants Product and Services
        2.15.4 Aphios Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Aphios Recent Developments/Updates

3 Competitive Environment: Vaccine Adjuvants by Manufacturer
    3.1 Global Vaccine Adjuvants Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Vaccine Adjuvants Revenue by Manufacturer (2018-2023)
    3.3 Global Vaccine Adjuvants Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Vaccine Adjuvants by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Vaccine Adjuvants Manufacturer Market Share in 2022
        3.4.2 Top 6 Vaccine Adjuvants Manufacturer Market Share in 2022
    3.5 Vaccine Adjuvants Market: Overall Company Footprint Analysis
        3.5.1 Vaccine Adjuvants Market: Region Footprint
        3.5.2 Vaccine Adjuvants Market: Company Product Type Footprint
        3.5.3 Vaccine Adjuvants Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Vaccine Adjuvants Market Size by Region
        4.1.1 Global Vaccine Adjuvants Sales Quantity by Region (2018-2029)
        4.1.2 Global Vaccine Adjuvants Consumption Value by Region (2018-2029)
        4.1.3 Global Vaccine Adjuvants Average Price by Region (2018-2029)
    4.2 North America Vaccine Adjuvants Consumption Value (2018-2029)
    4.3 Europe Vaccine Adjuvants Consumption Value (2018-2029)
    4.4 Asia-Pacific Vaccine Adjuvants Consumption Value (2018-2029)
    4.5 South America Vaccine Adjuvants Consumption Value (2018-2029)
    4.6 Middle East and Africa Vaccine Adjuvants Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Vaccine Adjuvants Sales Quantity by Type (2018-2029)
    5.2 Global Vaccine Adjuvants Consumption Value by Type (2018-2029)
    5.3 Global Vaccine Adjuvants Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Vaccine Adjuvants Sales Quantity by Application (2018-2029)
    6.2 Global Vaccine Adjuvants Consumption Value by Application (2018-2029)
    6.3 Global Vaccine Adjuvants Average Price by Application (2018-2029)

7 North America
    7.1 North America Vaccine Adjuvants Sales Quantity by Type (2018-2029)
    7.2 North America Vaccine Adjuvants Sales Quantity by Application (2018-2029)
    7.3 North America Vaccine Adjuvants Market Size by Country
        7.3.1 North America Vaccine Adjuvants Sales Quantity by Country (2018-2029)
        7.3.2 North America Vaccine Adjuvants Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Vaccine Adjuvants Sales Quantity by Type (2018-2029)
    8.2 Europe Vaccine Adjuvants Sales Quantity by Application (2018-2029)
    8.3 Europe Vaccine Adjuvants Market Size by Country
        8.3.1 Europe Vaccine Adjuvants Sales Quantity by Country (2018-2029)
        8.3.2 Europe Vaccine Adjuvants Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Vaccine Adjuvants Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Vaccine Adjuvants Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Vaccine Adjuvants Market Size by Region
        9.3.1 Asia-Pacific Vaccine Adjuvants Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Vaccine Adjuvants Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Vaccine Adjuvants Sales Quantity by Type (2018-2029)
    10.2 South America Vaccine Adjuvants Sales Quantity by Application (2018-2029)
    10.3 South America Vaccine Adjuvants Market Size by Country
        10.3.1 South America Vaccine Adjuvants Sales Quantity by Country (2018-2029)
        10.3.2 South America Vaccine Adjuvants Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Vaccine Adjuvants Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Vaccine Adjuvants Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Vaccine Adjuvants Market Size by Country
        11.3.1 Middle East & Africa Vaccine Adjuvants Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Vaccine Adjuvants Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Vaccine Adjuvants Market Drivers
    12.2 Vaccine Adjuvants Market Restraints
    12.3 Vaccine Adjuvants Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Vaccine Adjuvants and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Vaccine Adjuvants
    13.3 Vaccine Adjuvants Production Process
    13.4 Vaccine Adjuvants Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Vaccine Adjuvants Typical Distributors
    14.3 Vaccine Adjuvants Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Vaccine Adjuvants Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Vaccine Adjuvants Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. GSK Basic Information, Manufacturing Base and Competitors
    Table 4. GSK Major Business
    Table 5. GSK Vaccine Adjuvants Product and Services
    Table 6. GSK Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. GSK Recent Developments/Updates
    Table 8. CSL Limited Basic Information, Manufacturing Base and Competitors
    Table 9. CSL Limited Major Business
    Table 10. CSL Limited Vaccine Adjuvants Product and Services
    Table 11. CSL Limited Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. CSL Limited Recent Developments/Updates
    Table 13. Croda Basic Information, Manufacturing Base and Competitors
    Table 14. Croda Major Business
    Table 15. Croda Vaccine Adjuvants Product and Services
    Table 16. Croda Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Croda Recent Developments/Updates
    Table 18. SEPPIC Basic Information, Manufacturing Base and Competitors
    Table 19. SEPPIC Major Business
    Table 20. SEPPIC Vaccine Adjuvants Product and Services
    Table 21. SEPPIC Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. SEPPIC Recent Developments/Updates
    Table 23. Novavax Basic Information, Manufacturing Base and Competitors
    Table 24. Novavax Major Business
    Table 25. Novavax Vaccine Adjuvants Product and Services
    Table 26. Novavax Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Novavax Recent Developments/Updates
    Table 28. SPI Pharma Basic Information, Manufacturing Base and Competitors
    Table 29. SPI Pharma Major Business
    Table 30. SPI Pharma Vaccine Adjuvants Product and Services
    Table 31. SPI Pharma Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. SPI Pharma Recent Developments/Updates
    Table 33. Phibro Basic Information, Manufacturing Base and Competitors
    Table 34. Phibro Major Business
    Table 35. Phibro Vaccine Adjuvants Product and Services
    Table 36. Phibro Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Phibro Recent Developments/Updates
    Table 38. SDA BIO Basic Information, Manufacturing Base and Competitors
    Table 39. SDA BIO Major Business
    Table 40. SDA BIO Vaccine Adjuvants Product and Services
    Table 41. SDA BIO Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. SDA BIO Recent Developments/Updates
    Table 43. Invivogen Basic Information, Manufacturing Base and Competitors
    Table 44. Invivogen Major Business
    Table 45. Invivogen Vaccine Adjuvants Product and Services
    Table 46. Invivogen Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Invivogen Recent Developments/Updates
    Table 48. Tj Kaiwei Basic Information, Manufacturing Base and Competitors
    Table 49. Tj Kaiwei Major Business
    Table 50. Tj Kaiwei Vaccine Adjuvants Product and Services
    Table 51. Tj Kaiwei Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Tj Kaiwei Recent Developments/Updates
    Table 53. OZ Biosciences Basic Information, Manufacturing Base and Competitors
    Table 54. OZ Biosciences Major Business
    Table 55. OZ Biosciences Vaccine Adjuvants Product and Services
    Table 56. OZ Biosciences Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. OZ Biosciences Recent Developments/Updates
    Table 58. Brenntag Biosector Basic Information, Manufacturing Base and Competitors
    Table 59. Brenntag Biosector Major Business
    Table 60. Brenntag Biosector Vaccine Adjuvants Product and Services
    Table 61. Brenntag Biosector Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Brenntag Biosector Recent Developments/Updates
    Table 63. MVP Laboratories Basic Information, Manufacturing Base and Competitors
    Table 64. MVP Laboratories Major Business
    Table 65. MVP Laboratories Vaccine Adjuvants Product and Services
    Table 66. MVP Laboratories Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. MVP Laboratories Recent Developments/Updates
    Table 68. Zhuoyue Basic Information, Manufacturing Base and Competitors
    Table 69. Zhuoyue Major Business
    Table 70. Zhuoyue Vaccine Adjuvants Product and Services
    Table 71. Zhuoyue Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 72. Zhuoyue Recent Developments/Updates
    Table 73. Aphios Basic Information, Manufacturing Base and Competitors
    Table 74. Aphios Major Business
    Table 75. Aphios Vaccine Adjuvants Product and Services
    Table 76. Aphios Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Aphios Recent Developments/Updates
    Table 78. Global Vaccine Adjuvants Sales Quantity by Manufacturer (2018-2023) & (MT)
    Table 79. Global Vaccine Adjuvants Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 80. Global Vaccine Adjuvants Average Price by Manufacturer (2018-2023) & (USD/Kg)
    Table 81. Market Position of Manufacturers in Vaccine Adjuvants, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 82. Head Office and Vaccine Adjuvants Production Site of Key Manufacturer
    Table 83. Vaccine Adjuvants Market: Company Product Type Footprint
    Table 84. Vaccine Adjuvants Market: Company Product Application Footprint
    Table 85. Vaccine Adjuvants New Market Entrants and Barriers to Market Entry
    Table 86. Vaccine Adjuvants Mergers, Acquisition, Agreements, and Collaborations
    Table 87. Global Vaccine Adjuvants Sales Quantity by Region (2018-2023) & (MT)
    Table 88. Global Vaccine Adjuvants Sales Quantity by Region (2024-2029) & (MT)
    Table 89. Global Vaccine Adjuvants Consumption Value by Region (2018-2023) & (USD Million)
    Table 90. Global Vaccine Adjuvants Consumption Value by Region (2024-2029) & (USD Million)
    Table 91. Global Vaccine Adjuvants Average Price by Region (2018-2023) & (USD/Kg)
    Table 92. Global Vaccine Adjuvants Average Price by Region (2024-2029) & (USD/Kg)
    Table 93. Global Vaccine Adjuvants Sales Quantity by Type (2018-2023) & (MT)
    Table 94. Global Vaccine Adjuvants Sales Quantity by Type (2024-2029) & (MT)
    Table 95. Global Vaccine Adjuvants Consumption Value by Type (2018-2023) & (USD Million)
    Table 96. Global Vaccine Adjuvants Consumption Value by Type (2024-2029) & (USD Million)
    Table 97. Global Vaccine Adjuvants Average Price by Type (2018-2023) & (USD/Kg)
    Table 98. Global Vaccine Adjuvants Average Price by Type (2024-2029) & (USD/Kg)
    Table 99. Global Vaccine Adjuvants Sales Quantity by Application (2018-2023) & (MT)
    Table 100. Global Vaccine Adjuvants Sales Quantity by Application (2024-2029) & (MT)
    Table 101. Global Vaccine Adjuvants Consumption Value by Application (2018-2023) & (USD Million)
    Table 102. Global Vaccine Adjuvants Consumption Value by Application (2024-2029) & (USD Million)
    Table 103. Global Vaccine Adjuvants Average Price by Application (2018-2023) & (USD/Kg)
    Table 104. Global Vaccine Adjuvants Average Price by Application (2024-2029) & (USD/Kg)
    Table 105. North America Vaccine Adjuvants Sales Quantity by Type (2018-2023) & (MT)
    Table 106. North America Vaccine Adjuvants Sales Quantity by Type (2024-2029) & (MT)
    Table 107. North America Vaccine Adjuvants Sales Quantity by Application (2018-2023) & (MT)
    Table 108. North America Vaccine Adjuvants Sales Quantity by Application (2024-2029) & (MT)
    Table 109. North America Vaccine Adjuvants Sales Quantity by Country (2018-2023) & (MT)
    Table 110. North America Vaccine Adjuvants Sales Quantity by Country (2024-2029) & (MT)
    Table 111. North America Vaccine Adjuvants Consumption Value by Country (2018-2023) & (USD Million)
    Table 112. North America Vaccine Adjuvants Consumption Value by Country (2024-2029) & (USD Million)
    Table 113. Europe Vaccine Adjuvants Sales Quantity by Type (2018-2023) & (MT)
    Table 114. Europe Vaccine Adjuvants Sales Quantity by Type (2024-2029) & (MT)
    Table 115. Europe Vaccine Adjuvants Sales Quantity by Application (2018-2023) & (MT)
    Table 116. Europe Vaccine Adjuvants Sales Quantity by Application (2024-2029) & (MT)
    Table 117. Europe Vaccine Adjuvants Sales Quantity by Country (2018-2023) & (MT)
    Table 118. Europe Vaccine Adjuvants Sales Quantity by Country (2024-2029) & (MT)
    Table 119. Europe Vaccine Adjuvants Consumption Value by Country (2018-2023) & (USD Million)
    Table 120. Europe Vaccine Adjuvants Consumption Value by Country (2024-2029) & (USD Million)
    Table 121. Asia-Pacific Vaccine Adjuvants Sales Quantity by Type (2018-2023) & (MT)
    Table 122. Asia-Pacific Vaccine Adjuvants Sales Quantity by Type (2024-2029) & (MT)
    Table 123. Asia-Pacific Vaccine Adjuvants Sales Quantity by Application (2018-2023) & (MT)
    Table 124. Asia-Pacific Vaccine Adjuvants Sales Quantity by Application (2024-2029) & (MT)
    Table 125. Asia-Pacific Vaccine Adjuvants Sales Quantity by Region (2018-2023) & (MT)
    Table 126. Asia-Pacific Vaccine Adjuvants Sales Quantity by Region (2024-2029) & (MT)
    Table 127. Asia-Pacific Vaccine Adjuvants Consumption Value by Region (2018-2023) & (USD Million)
    Table 128. Asia-Pacific Vaccine Adjuvants Consumption Value by Region (2024-2029) & (USD Million)
    Table 129. South America Vaccine Adjuvants Sales Quantity by Type (2018-2023) & (MT)
    Table 130. South America Vaccine Adjuvants Sales Quantity by Type (2024-2029) & (MT)
    Table 131. South America Vaccine Adjuvants Sales Quantity by Application (2018-2023) & (MT)
    Table 132. South America Vaccine Adjuvants Sales Quantity by Application (2024-2029) & (MT)
    Table 133. South America Vaccine Adjuvants Sales Quantity by Country (2018-2023) & (MT)
    Table 134. South America Vaccine Adjuvants Sales Quantity by Country (2024-2029) & (MT)
    Table 135. South America Vaccine Adjuvants Consumption Value by Country (2018-2023) & (USD Million)
    Table 136. South America Vaccine Adjuvants Consumption Value by Country (2024-2029) & (USD Million)
    Table 137. Middle East & Africa Vaccine Adjuvants Sales Quantity by Type (2018-2023) & (MT)
    Table 138. Middle East & Africa Vaccine Adjuvants Sales Quantity by Type (2024-2029) & (MT)
    Table 139. Middle East & Africa Vaccine Adjuvants Sales Quantity by Application (2018-2023) & (MT)
    Table 140. Middle East & Africa Vaccine Adjuvants Sales Quantity by Application (2024-2029) & (MT)
    Table 141. Middle East & Africa Vaccine Adjuvants Sales Quantity by Region (2018-2023) & (MT)
    Table 142. Middle East & Africa Vaccine Adjuvants Sales Quantity by Region (2024-2029) & (MT)
    Table 143. Middle East & Africa Vaccine Adjuvants Consumption Value by Region (2018-2023) & (USD Million)
    Table 144. Middle East & Africa Vaccine Adjuvants Consumption Value by Region (2024-2029) & (USD Million)
    Table 145. Vaccine Adjuvants Raw Material
    Table 146. Key Manufacturers of Vaccine Adjuvants Raw Materials
    Table 147. Vaccine Adjuvants Typical Distributors
    Table 148. Vaccine Adjuvants Typical Customers
List of Figures
    Figure 1. Vaccine Adjuvants Picture
    Figure 2. Global Vaccine Adjuvants Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Vaccine Adjuvants Consumption Value Market Share by Type in 2022
    Figure 4. Aluminum Adjuvant Examples
    Figure 5. Emulsions Adjuvant Examples
    Figure 6. Others Examples
    Figure 7. Global Vaccine Adjuvants Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 8. Global Vaccine Adjuvants Consumption Value Market Share by Application in 2022
    Figure 9. Human Vaccine Examples
    Figure 10. Veterinary Vaccine Examples
    Figure 11. Global Vaccine Adjuvants Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Vaccine Adjuvants Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Vaccine Adjuvants Sales Quantity (2018-2029) & (MT)
    Figure 14. Global Vaccine Adjuvants Average Price (2018-2029) & (USD/Kg)
    Figure 15. Global Vaccine Adjuvants Sales Quantity Market Share by Manufacturer in 2022
    Figure 16. Global Vaccine Adjuvants Consumption Value Market Share by Manufacturer in 2022
    Figure 17. Producer Shipments of Vaccine Adjuvants by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 Vaccine Adjuvants Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Top 6 Vaccine Adjuvants Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Global Vaccine Adjuvants Sales Quantity Market Share by Region (2018-2029)
    Figure 21. Global Vaccine Adjuvants Consumption Value Market Share by Region (2018-2029)
    Figure 22. North America Vaccine Adjuvants Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe Vaccine Adjuvants Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific Vaccine Adjuvants Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America Vaccine Adjuvants Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East & Africa Vaccine Adjuvants Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global Vaccine Adjuvants Sales Quantity Market Share by Type (2018-2029)
    Figure 28. Global Vaccine Adjuvants Consumption Value Market Share by Type (2018-2029)
    Figure 29. Global Vaccine Adjuvants Average Price by Type (2018-2029) & (USD/Kg)
    Figure 30. Global Vaccine Adjuvants Sales Quantity Market Share by Application (2018-2029)
    Figure 31. Global Vaccine Adjuvants Consumption Value Market Share by Application (2018-2029)
    Figure 32. Global Vaccine Adjuvants Average Price by Application (2018-2029) & (USD/Kg)
    Figure 33. North America Vaccine Adjuvants Sales Quantity Market Share by Type (2018-2029)
    Figure 34. North America Vaccine Adjuvants Sales Quantity Market Share by Application (2018-2029)
    Figure 35. North America Vaccine Adjuvants Sales Quantity Market Share by Country (2018-2029)
    Figure 36. North America Vaccine Adjuvants Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Canada Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Mexico Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Europe Vaccine Adjuvants Sales Quantity Market Share by Type (2018-2029)
    Figure 41. Europe Vaccine Adjuvants Sales Quantity Market Share by Application (2018-2029)
    Figure 42. Europe Vaccine Adjuvants Sales Quantity Market Share by Country (2018-2029)
    Figure 43. Europe Vaccine Adjuvants Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. France Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. United Kingdom Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Russia Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Italy Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific Vaccine Adjuvants Sales Quantity Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific Vaccine Adjuvants Sales Quantity Market Share by Application (2018-2029)
    Figure 51. Asia-Pacific Vaccine Adjuvants Sales Quantity Market Share by Region (2018-2029)
    Figure 52. Asia-Pacific Vaccine Adjuvants Consumption Value Market Share by Region (2018-2029)
    Figure 53. China Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Japan Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Korea Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. India Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Southeast Asia Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Australia Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. South America Vaccine Adjuvants Sales Quantity Market Share by Type (2018-2029)
    Figure 60. South America Vaccine Adjuvants Sales Quantity Market Share by Application (2018-2029)
    Figure 61. South America Vaccine Adjuvants Sales Quantity Market Share by Country (2018-2029)
    Figure 62. South America Vaccine Adjuvants Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Argentina Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Middle East & Africa Vaccine Adjuvants Sales Quantity Market Share by Type (2018-2029)
    Figure 66. Middle East & Africa Vaccine Adjuvants Sales Quantity Market Share by Application (2018-2029)
    Figure 67. Middle East & Africa Vaccine Adjuvants Sales Quantity Market Share by Region (2018-2029)
    Figure 68. Middle East & Africa Vaccine Adjuvants Consumption Value Market Share by Region (2018-2029)
    Figure 69. Turkey Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Egypt Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Saudi Arabia Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. South Africa Vaccine Adjuvants Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Vaccine Adjuvants Market Drivers
    Figure 74. Vaccine Adjuvants Market Restraints
    Figure 75. Vaccine Adjuvants Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Vaccine Adjuvants in 2022
    Figure 78. Manufacturing Process Analysis of Vaccine Adjuvants
    Figure 79. Vaccine Adjuvants Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Vaccine Adjuvants Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Vaccine Adjuvants Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 12 Sep 2024

date Pharma & Healthcare

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

Global Vaccine Adjuvants Supply, Demand and Key Producers, 2024-2030

Global Vaccine Adjuvants Supply, Demand and Key Producers, 2024-2030

date 12 Sep 2024

date Pharma & Healthcare

Product Tags

Vaccine Adjuvants

Veterinary Vaccine Adjuvants

Human Vaccine Adjuvants

Intramuscular Vaccine Adjuvants

Subcutaneous Vaccine Adjuvants

Oral Vaccine Adjuvants

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>